Literature DB >> 6270550

The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium.

J Van Cutsem, M Borgers, M De Brabander.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270550

Source DB:  PubMed          Journal:  Mykosen        ISSN: 0027-5557


× No keyword cloud information.
  5 in total

1.  Inhibition of germ tube formation, filamentation and ergosterol biosynthesis in Candida albicans treated with 6-amino-2-n-pentylthiobenzothiazole.

Authors:  S Fábry; S Gáborová; H Bujdáková; M Klobusický; A Volleková; T Kuchta
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

Review 2.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

3.  In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.

Authors:  D G Ahearn; M S McGlohn
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

4.  Hematogenous Candida vertebral osteomyelitis treated with ketoconazole.

Authors:  B A Dijkmans; M I Koolen; R P Mouton; T H Falke; P J van den Broek; J W van der Meer
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

5.  Itraconazole, a new triazole that is orally active in aspergillosis.

Authors:  J Van Cutsem; F Van Gerven; M A Van de Ven; M Borgers; P A Janssen
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.